Facilitated By

San Antonio Medical Foundation

Effect of CDDO-2P-Im on COVID-19 Infection in Cell Culture

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Dwivedi, Varun
Funded by
Triterpenoid Therapeutics
Research Start Date
Status
Active

The major goal is to determine if CDDO-2p-lm inhibits uptake/entry, replication, and release of virus, as well as inhibiting cytopathic effects and excessive inflammation caused by virus (induction of excessive secretion of cytokines, "cytokine storm").

Collaborative Project
Drug Discovery
Infectious Disease